Neurology Care, Diagnostics, and Emerging Therapies of the Patient With Duchenne Muscular Dystrophy.

Leigh, Fawn; Ferlini, Alessandra; Biggar, Doug; Bushby, Katharine; Finkel, Richard; Morgenroth, Lauren P; Wagner, Kathryn R

Leigh, Fawn; Ferlini, Alessandra; Biggar, Doug; Bushby, Katharine; Finkel, Richard; Morgenroth, Lauren P; Wagner, Kathryn R.

Afiliação

Leigh F; Massachusetts General Hospital and Harvard Medical School, Harvard University, Cambridge, Massachusetts; fawn.leigh@seattlechildrens.org.
Ferlini A; Seattle Children's Hospital, University of Washington, Seattle, Washington.
Biggar D; University of Ferrara, Ferrara, Italy.
Bushby K; Holland Bloorview Kids Rehabilitation Hospital, Toronto, Ontario, Canada.
Finkel R; John Walton Centre for Muscular Dystrophy Research, Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
Morgenroth LP; Nemours Children's Health System, Orlando, Florida.
Wagner KR; Children's National Health System, Washington, District of Columbia.

Pediatrics ; 142(Suppl 2): S5-S16, 2018 10.

Article em En | MEDLINE | ID: mdl-30275245

Assuntos

Distrofia Muscular de Duchenne/terapia; Adolescente; Criança; Pré-Escolar; Terapia Genética/métodos; Glucocorticoides/uso terapêutico; Humanos; Terapia de Alvo Molecular/métodos; Distrofia Muscular de Duchenne/diagnóstico; Neurologia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Distrofia Muscular de Duchenne Tipo de estudo: Diagnostic_studies / Screening_studies Limite: Adolescent / Child / Child, preschool / Humans Idioma: En Revista: Pediatrics Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google